Because AATS members are leaders in the field of cardiothoracic surgery, they are an excellent resource for members of the media. To request an interview, or to discuss what information the AATS can provide, please contact: Alexis Merry Marketing Manager 978-252-220, Ext. 525 press@aats.org
If you are interested in covering or publicizing studies presented at the AATS Annual Meeting, please read the AATS media and embargo policies.
President's Message
Dr. Marshall Appointed New Editor of Operative Techniques
AATS Statement on Transparency of Clinical Research Data
Call for Applications: Editor, Operative Techniques in Thoracic and Cardiovascular Surgery: A Comparative Atlas
JTCVS Impact Factor Reaches All-Time High
David J. Sugarbaker, 94th AATS President Passes Away
Vaughn A. Starnes Assumes Presidency of the American Association for Thoracic Surgery
Clinical Trial Shows Promise for Increasing Lung Transplant Patients’ Life Expectancy Trans-Catheter Aortic Valve Replacement Can Improve Outcomes in Low-Risk Surgical Patients A New Technique for Minimally Invasive Surgery in Lung Cancer – Ultrasonic Device is Safe and Effective for Lung Vessel Sealing in Minimally Invasive Lobectomy Clinical Trial Concludes Transcatheter Aortic Valve Replacement Can Be Considered for Patients in All Surgical Risk Classes New Model Improves Staging and Risk Predictions for Esophageal Cancer Patients
David H. Adams Assumes Presidency
Opioids over-prescribed after hiatal hernia surgery
For patients with esophageal cancer, status of lymph nodes after preoperative therapy determines survival
Practice-Changing Study on Coronary Bypass Surgery
World’s first series of robot-assisted tracheobronchoplasty shows promise for successful treatment of tracheobronchomalacia
Mandatory public reporting of coronary artery bypass grafting associated with better patient outcomes
Surgery soon after clinical staging of non-small cell lung cancer reduces cancer progression and improves likelihood of cure
Dr. Scott J. Swanson on Prospective, Multi-Center, International Phase 2 Trial Evaluating Ultrasonic Energy for Pulmonary Artery Branch Sealing in VATS Lobectomy Dr. Jonathan C. Yeung on Patient-Derived Esophageal Adenocarcinoma Organoids Recapitulate the Primary Tumor Dr. Varun Puri on A Clinical Nomogram for Predicting Node Positive Disease in Esophageal Cancer Dr. Theodore J. M. Fischlein on Comparison Between Minimally Invasive and Standard Surgical Aortic Valve Replacement: A Multi-Center Propensity Matched Study Dr. Patrick M. McCarthy and Dr. Niv Ad discussing Ten-Year Outcomes Following the Cox-Maze IV Procedure for Atrial Fibrillation Dr. Patrick T. O’Gara and Dr. Niv Ad discussing MitraClip Implantation in Patients with Heart Failure and Secondary Mitral Regurgitation (the COAPT trial): Impact of Effective Regurgitation Orifice Area, Left Ventricular Size and other Variables on MitraClip Response Dr. Eugene H. Blackstone on Effect of Total Arterial Grafting in the Arterial Revascularization Trial
Alyssa Mazurek on Opioid Over-Prescription After Open and Laparoscopic Hiatal Hernia Repair
David Nelson on Close Surgical Margins and Risks of Local Treatment Failure after Wedge Resection of Colorectal Pulmonary Metastases
Gorav Ailawadi 1. Impact of Public Reporting on Risk Aversion in Cardiac Surgery and 2. Is Routine Extubation Overnight Safe in Cardiac Surgery Patients.
Harmik Soukiasian on Effects of Time From Completed Clinical Staging to Surgery: Does it Make a Difference in Stage 1 Non-Small Lung Cancer?
Richard Lazzaro on First Series of Minimally Invasive, Robot-Assisted Tracheobronchoplasty with Mesh for Severe Tracheobronchomalacia
Michael Mack, Mario Gaudino, and David Taggert on Radial Artery Versus Saphenous Vein in Coronary Artery Bypass Surgery
Nasser Altorki on Extent of Lymphadenctomy is Associated with Oncological Efficacy of Sublobar Resection for Lung Cancer Less than or Equal to 2 cm
Shawn Groth on Prognostic Value of Neoadjuvant Treatment Response in Locally Advanced Esophageal Adenocarcinoma
Stephen Broderick on Operative Experience with Pulmonary Resection following Neoadjuvant Nivolumab in Patients with Resectable Non-small Cell Lung Cancer